Johnson & Johnson will invest $55 billion in U.S. manufacturing, research and technology over the next four years, marking a 25% increase in investment for the company.
The expansion will include four new manufacturing facilities, with the first breaking ground March 21 in Wilson, N.C., according to a March 21 news release from the company.
The 500,000-square-foot biologics plant is expected to create 500 permanent jobs and support 5,000 construction jobs.
Beyond North Carolina, J&J plans to expand on existing facilities and invest in oncology, neuroscience, immunology, cardiovascular treatments and robotic surgery. The company’s total economic U.S. impact is estimated at over $100 billion annually, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
